News

Barrick Mining's Strategic Sale of Hemlo Gold Mine Explained

Barrick Mining's Strategic Sale of Hemlo Gold Mine Explained

Barrick Mining's Strategic Sale of Hemlo Gold Mine

All amounts expressed in U.S. dollars.

Barrick Mining Corporation (NYSE:B)(TSX:ABX) has announced a significant step in its journey by reaching an agreement to divest the Hemlo Gold Mine to Carcetti Capital Corp, which will be rebranded as Hemlo Mining Corp (HMC) upon closing this deal.

This transaction is valued at up to $1.09 billion, a substantial amount that reaffirms Barrick's strategic focus on optimizing its asset portfolio. The total proceeds include:

  • Cash payment of $875 million due at closing.
  • Shares of HMC valued at $50 million, based on the company's concurrent equity offering to be issued upon closure.
  • A structured cash payment linked to production and gold prices, potentially adding up to $165 million commencing in January 2027 over a five-year period.

HMC is currently listed on the NEX Board of the TSX Venture Exchange and anticipates a successful graduation to the TSXV in conjunction with taking ownership of Hemlo. HMC brings a robust management team, including Robert Quartermain, formerly the CEO of SSR Mining Inc., who has extensive operational expertise in the mining sector.

This strategic move also showcases HMC's backing by notable investors focused on advancing North American resource development. This includes partnerships with Wheaton Precious Metals and Orion Mine Finance Management, highlighting a solid foundation for HMC's future endeavors.

The capital generated from this transaction will significantly enhance Barrick's financial standing and facilitate the company's ongoing commitment to return value to its shareholders. Barrick's president and CEO, Mark Bristow, expressed confidence in the excellent stewardship of Hemlo under HMC's experienced management team.

Moreover, Bristow pointed out the successful sales of other non-core assets, including Donlin and Alturas, which are expected to result in a total of over $2 billion in gross proceeds. This highlights Barrick's strategic approach in focusing on its core assets by divesting non-essential projects while maximizing shareholder returns.

Barrick remains committed to Canada as a key region for its operations and aims to continually explore and develop world-class gold and copper mines. The company possesses a variety of promising early-stage projects, ensuring its presence in the region remains robust.

The completion of this transaction hinges on fulfilling customary closing conditions and acquiring necessary regulatory approvals, with an anticipated finish within the fourth quarter.

CIBC World Markets Inc. has been engaged as the financial advisor for this transaction, while Davies Ward Phillips & Vineberg LLP and Blake, Cassels & Graydon LLP provide legal counsel, ensuring a thorough and professional process.

About Barrick Mining Corporation

Barrick Mining Corporation is a prominent global player in the mining, exploration, and development sectors. With an extensive portfolio of premier gold and copper assets, including six of the world’s Tier One gold mines, Barrick operates in 18 countries across five continents. Its commitment to responsible mining and building strong partnerships is at the forefront of its operations. Shares of Barrick are traded on the New York Stock Exchange under the symbol ‘B’ and on the Toronto Stock Exchange under ‘ABX’.

Frequently Asked Questions

What is the financial value of the Hemlo Gold Mine sale?

The Hemlo Gold Mine is being sold for up to $1.09 billion, including various payment structures.

Who is Hemlo Mining Corp?

Hemlo Mining Corp, initially Carcetti Capital Corp, is the buyer of the Hemlo Gold Mine and will focus on developing and operating the mine.

What will Barrick do with the proceeds from the sale?

The proceeds from the Hemlo sale will strengthen Barrick's balance sheet and support capital return initiatives for shareholders.

What does this sale indicate about Barrick's strategy?

This sale emphasizes Barrick's strategy to focus on its core gold and copper portfolio, enhancing its financial solidity and growth potential.

How does Barrick plan to maintain its operations in Canada?

Barrick aims to pursue opportunities for developing world-class gold and copper mines while further exploring early-stage projects in Canada.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Halozyme Therapeutics Boosts Revenue Guidance, Analysts React

Updated Category News Views 33

Halozyme Therapeutics' Earnings Performance Insights Recently, analysts adjusted their outlook for Halozyme Therapeutics (NASDAQ: HALO), following a robust earnings report for the third quarter of 2024. Piper Sandler increased its price target to $52 from $51, while maintaining a Neutral rating on the stock. This adjustment came in light of Halozyme's impressive...

Continue Reading
DarioHealth's Innovative Digital Health Platform Cuts Costs

Updated Category News Views 154

DarioHealth Announces Major Findings in Cost Reduction Recently, DarioHealth Corp. (NASDAQ: DRIO), a frontrunner in digital health solutions, revealed significant findings regarding the cost reductions associated with its innovative digital health platform. This research, presented at a prominent health economics and outcomes conference, highlights the company's...

Continue Reading
Antibody Drug Conjugates Market Insights and Growth Forecast

Updated Category News Views 67

Overview of the Antibody Drug Conjugates Market The Global Antibody Drug Conjugates (ADCs) Market is experiencing impressive growth, with projections indicating an increase from USD 13.7 billion in 2024 to a remarkable USD 51.2 billion by 2033. This growth represents a compound annual growth rate (CAGR) of 15.8%. The rise is primarily driven by the increasing prevalence...

Continue Reading
Haut.AI Enhances Neutrogena Skin360 with Innovative AI Tech

Updated Category News Views 296

Reimagining the Neutrogena Skin360 Experience Haut.AI is thrilled to reveal its collaboration with Neutrogena to revamp the renowned Skin360 experience. This refresh integrates Haut.AI's state-of-the-art AI skin analysis technology, allowing for hyper-personalized skincare recommendations tailored to each user's unique skin needs. This innovative approach utilizes...

Continue Reading
Associates in Gastroenterology: A Leader in Patient-Centered Care

Updated Category News Views 71

Associates in Gastroenterology: A Leader in Patient-Centered Care Associates in Gastroenterology (AiG) is a prominent gastroenterology practice dedicated to delivering outstanding patient care. Located in Nashville, AiG prioritizes comprehensive digestive health services that respond to the diverse needs of the local community. Commitment to Exceptional Care Dr. Kevin...

Continue Reading